Progress in vaccine trials ‘promising’

Positive outlook: Visitors at a fair in Shanghai seen wearing face masks. Chinese trials have discovered a Covid-19 vaccine candidate that is safe, according to research published in ‘The Lancet’journal. — Reuters

BEIJING: The phase-two clinical trial of the Covid-19 vaccine candidate created by the Academy of Military Medical Sciences and Chinese biotech company CanSino Biologics has found that it is safe and can induce an immune response, according to research published in The Lancet medical journal.

Also on Monday, the journal published the results of phase-one and phase-two clinical trials of a similar adenovirus vectored vaccine developed by scientists at Oxford University and biotech company AstraZeneca. That vaccine also demonstrated success in safety and potency against Covid-19.